NLS

All over the world, countries are experiencing a demographic shift towards aging populations. The field of aging research seeks to answer the question of how we can age healthier, and not just live longer.

In a sector long dominated by the US and Europe, Mainland China is now catching up in global pharma and biotechnology. 

Even though many have tried and few succeeded in the quest to find viable treatments for neurodegenerative diseases, Nordic drug developers continue to take different approaches to crack the riddle.

Understanding the science is one thing, but being able to manufacture T-cell therapies at scale is a different matter. TCR-T cell therapies offer a path forward at a fraction of the cost and time of manufacturing a living cell as a product. 

More than three decades after their discovery of microRNA, Professor Gary Ruvkun received the “mythic call” from Stockholm to learn that he’d been awarded the Nobel Prize in Physiology or Medicine alongside his erstwhile colleague Victor Ambros.

BIO-Europe 2024 was held at Stockholmsmässan in Älvsjö on November 4-6, and Nordic Life Science asked three Norwegian life science profiles about their impressions and reasons for attending.